ArticleMedComm2026

Neoadjuvant Toripalimab Plus Axitinib for Nonmetastatic Clear Cell Renal Cell Carcinoma With Tumor Thrombus: A Combined Analysis of Two Phase II Clinical Trials.

Cheng Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.